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Abstract
Background: Children and adolescents still lag behind adults in accessing antiretroviral therapy (ART), which is
largely due to their limited access to HIV testing services. This study compares the acceptability, feasibility and
effectiveness of targeted versus blanket provider-initiated testing and counseling (PITC) among children and
adolescents in Cameroon.
Methods: During a 6-month period in three hospitals in Cameroon, we invited HIV-positive parents to have their
biological children (6 weeks-19 years) tested for HIV (targeted PITC). During that same period and in the same hospitals,
we also systematically offered HIV testing to all children evaluated at the outpatient department (blanket PITC).
Children of consenting parents were tested for HIV, and positive cases were enrolled on ART. We compared the
acceptability, feasibility and effectiveness of targeted and blanket PITC using Chi-square test at 5% significant level.
Results: We enrolled 1240 and 2459 eligible parents in the targeted PITC (tPITC) and blanket PITC (bPITC) group, and
99.7% and 98.8% of these parents accepted the offer to have their children tested for HIV, respectively. Out of the 1990
and 2729 children enrolled in the tPITC and bPITC group, 56.7% and 90.3% were tested for HIV (p < 0.0001),
respectively. The HIV positivity rate was 3.5% (CI:2.4–4.5) and 1.6% (CI:1.1–2.1) in the tPITC and bPITC (p = 0.0008),
respectively. This finding suggests that the case detection was two times higher in tPITC compared to bPITC, or
alternatively, 29 and 63 children have to be tested to identify one HIV case with the implementation of tPITC and
bPITC, respectively. The majority (84.8%) of HIV-positive children in the tPITC group were diagnosed earlier at WHO stage
1, and cases were mostly diagnosed at WHO stage 3 (39.1%) (p < 0.0001) in the bPITC group. Among the children who
tested HIV-positive, 85.0% and 52.5% from the tPITC and bPITC group respectively, were enrolled on ART (p = 0.0018).
Conclusions: The tPITC and bPITC strategies demonstrated notable high HIV testing acceptance. tPITC was superior to
bPITC in terms of case detection, case detection earliness and linkage to care. These findings indicate that tPITC is
effective in case detection and linkage of children and adolescents to ART.
Trial registration: Trial registration Number: NCT03024762. Name of Registry: ClinicalTrial.gov. Date registration: January
19, 2017 (‘retrospectively registered’). Date of enrolment first patient: 15/07/2015.
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Background
Human immunodeficiency virus (HIV) case identifica-
tion has been and remains a major obstacle to the ex-
pansion of antiretroviral therapy (ART) among infants,
children and adolescents in sub-Saharan Africa due to
multifaceted barriers at the patient, provider, community
and national policy levels [1]. The uptake of early infant
diagnosis (EID) using deoxyribonucleic acid-polymerase
chain reaction (DNA-PCR) techniques for infants youn-
ger than 18 months of age is sub-optimal with a global
coverage of 50% [2]. This gap is due to numerous bar-
riers, including low antenatal consultation (ANC) at-
tendance, weak supply chain management of pediatric
HIV commodities, low retention, delayed test results,
weak follow-up after delivery and poor linkage to treat-
ment [3]. Implementation of the routine or blanket
provider-initiated-testing and counseling (PITC), a strat-
egy recommended by the World Health Organization
(WHO) for HIV case finding among older children
(≥18 months) is fragmentary. This situation is attribut-
able to many factors, including fear of stigma, lack of
staff training, lack of HIV testing kits, poor commitment
from facility leadership, and missed parental consent to
test children [4, 5].
As a result of these programmatic gaps, only approxi-
mately 10% and 15% of HIV-infected young (15–24 years)
males and females, respectively, in Sub-Saharan Africa are
aware of their HIV status [6]. As the gateway to HIV treat-
ment and care, this low HIV testing uptake among chil-
dren and adolescents translates to the current low
pediatric ART coverage with only 43% of eligible children
being on treatment compared to 54% of adults [7].
In Cameroon, the pediatric ART coverage gap is even
wider, with only 18% of eligible children being on ART
compared with 38% of adults [8]. This is happening des-
pite the availability of HIV commodities (testing kits and
antiretroviral drugs) provided free of charge for children
by the government of Cameroon with the support of ex-
ternal funding agencies, most notably the Global Fund
to fight HIV/AIDS, Tuberculosis and Malaria (GFATM)
and the United States President’s Emergency Plan for
AIDS Relief (PEPFAR). This gap indicates the need for
alternative and/or innovative approaches to increase
pediatric and adolescent HIV case identification and
linkage to care in Cameroon and globally.
Given that over 90% [9] of pediatric HIV infections result
from mother to child transmission, targeting with HIV test-
ing, children of parents living with HIV/AIDS is a plausible
high-yield case finding strategy as indicated by a study con-
ducted in 2006 in Cameroon [10]. Though recommended
by WHO since 2010 [11], implementation of this targeted
PITC (tPITC) strategy is still sub-optimal in Cameroon and
in other sub-Saharan African countries. Currently, there is
a dearth of literature on the implementation outcome of
tPITC, and most importantly, there is a lack of knowledge
on its comparative advantage over the blanket PITC
(bPITC). This study aimed to bridge this evidence gap and
to contribute to the expansion of HIV treatment and care
among children and adolescents.
Methods
Design
We conducted an interventional study in which we in-
vited all parents living with HIV/AIDS receiving HIV
care in three hospitals in Cameroon to have their chil-
dren of unknown HIV status aged 6 weeks to 19 years to
be tested for HIV (tPITC group). In the same hospitals,
all parents/guardians who accompanied their sick chil-
dren of the same age group for consultation at the out-
patient departments were also counseled, and these
children were invited to test for HIV irrespective of the
presenting complaint (bPITC group).
Setting
The study was conducted in the Limbe Regional Hospital
(LRH), Ndop District Hospital (NDH) and Abong-Mbang
District Hospital (ADH). These hospitals provide compre-
hensive health care services to the catchment population,
including the management of HIV/AIDS. The study was
conducted within the Active Search for Pediatric HIV/
AIDS (ASPA) project, an initiative of Research for Develop-
ment (R4D) International Foundation, a Cameroon-based
global health research non-governmental organization. The
ASPA project aimed to promote pediatric HIV service
delivery through a range of activities, including capacity
building of health personnel, services delivery both at facil-
ity and community level, nutritional support, monitoring
and evaluation.
Study period and population
Data were collected in the LRH from July to December
2015, and in ADH and NDH from June to November 2016.
The study population in the tPITC group consisted of
parents living with HIV/AIDS receiving care in the hospital
and their children of unknown HIV status, aged 6 weeks
to 19 years. Similarly, in the bPITC group, the study
population consisted of parents/guardians and their
sick children of the same age group who attended the
hospital outpatient department for any reason. Children
or parents critically ill (in vital distress) were excluded
from the study.
Study procedures
Site preparation
Prior to the study, input and support provided by the
project to the respective hospitals included the follow-
ing: staff training on both tPITC and bPITC activities,
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provision of HIV testing kits, and human resource sup-
port (dedicated staff to support project implementation).
Enrollment of participants and data collection
In the tPITC group, HIV-positive parents in care at the
HIV treatment center (ART clinic) were counseled and
invited by a trained counselor to participate in the study
together with their children with unknown HIV status.
These parents were offered a testing opportunity for
their biological children in either the hospital or at home
(community testing). In the bPITC group, parents/
guardians were also counseled and invited to have their
sick children tested for HIV irrespective of the reason of
consultation.
In both groups, all parents/guardians who consented
to participate in the study were enrolled together with
their children. Pre-tested and structured questionnaires
(Additional file 1: Questionaires 1–4) were used by a
trained data clerk to collect socio-demographic informa-
tion and the HIV/AIDS history of parents and children
(Fig. 1). In the tPITC group, a sub-population of parents
who initially agreed to bring their children for HIV testing,
but subsequently did not, were interviewed using a struc-
tured questionnaire (Additional file 2: Questionaire 5) and
this to determine the reason of their failure to bring
children for testing.
HIV testing, linkage and ART enrolment
For children younger than 18 months of age, HIV testing
was performed using DNA-PCR techniques. For children
older than 18 months, HIV testing was performed using
two HIV antibody rapid tests according to the Cameroon
national guidelines. The WHO test and treat policy was
not effective at the site level at the time of the study.
Thus, children who tested positive for HIV were
assessed for ART eligibility using WHO clinical staging
Fig. 1 Enrollment, HIV testing and linkage to care and treatment of children and adolescents, ASPA Study, July–November 2016, Cameroon
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and/or baseline biological analysis, including CD4 count.
Eligible children were initiated on ART and monitored
according to the Cameroon national guidelines.
Sample size
We used the following formula to calculate the sample
size for 2 proportions with dichotomous outcome [12]:
N ¼ Zα=2 þ Zβ
 2  p1 1−p1ð Þ þ p2 1−p2ð Þð Þ= p1−p2ð Þ2;
Where: α = 5%, β = 20%, p1 = 10%, p2 = 5%. We found
N = 432 children and adolescents per group and per hos-
pital or 1296 per group for the three hospitals. Thus, a
total of n = 1296 × 2 = 2592 children and adolescents for
the two groups and three hospitals.
Data management and analysis
Anonymous data from the questionnaires were entered
into a database and analyzed using STATA 2013 (College
Station, TX: StataCorp LP). The study outcomes were
determined by computing the proportions and compar-
ing the values using Chi-square test (X2) at 5% signifi-
cant level.
Definitions of terms
The study outcomes were defined and calculated as follows:
i) Acceptability (acceptance rate): proportion of
parents who accepted to have their children tested
among all eligible parents enrolled in the study
ii) Feasibility (HIV testing uptake rate): proportion of
children who tested for HIV among all eligible
children identified by the study
iii) Effectiveness: It was defined and measured as
follows:
a) HIV case detection/positivity rate: proportion of
HIV cases detected among children and
adolescents tested for HIV
b) HIV case detection earliness: proportion of cases
detected at WHO stage 1
c) ART linkage rate: proportion of cases linked to
care or enrolled on ART
Results
Acceptability of tPITC and bPITC
The study offered enrolment to 3699 parents, including
1240 and 2459 in the tPITC and bPITC groups, respect-
ively. In both groups, parents were predominantly from
Ndop District Hospital (38.6%), followed by Limbe Re-
gional Hospital (36.4%) and Abong-Mbang District Hos-
pital (25.0%). Among these parents, 99.7% (1236/1240)
and 98.8% (2430/2459) in the tPITC and bPITC, respect-
ively, accepted to have their children tested for HIV.
Feasibility of tPITC and bPITC
Through parents, 4719 eligible children were enrolled
for HIV testing, including 1990 and 2729 in the tPITC
and bPITC groups, respectively. In both groups, the chil-
dren were predominantly from Ndop District Hospital
Hospital (41.1%), followed by Limbe Regional Hospital
(37.2%) and Abong-Mbang District Hospital (21.7%)
(Table 1). None of the children enrolled had refused to
be tested for HIV. Among the participating children,
56.7% (1129/1990) and 90.3% (2465/2729) (p < 0.0001)
tested for HIV, respectively, in the tPITC and bPITC
groups (Table 2). Among children ≤12 years, the HIV
Table 1 Uptake of HIV services among children and adolescents in three hospitals in Cameroon, ASPA study, July 2015–November
2016
HIV services tPITC bPITC
Limbe Abong-Mbang Ndop Total Limbe Abong-Mbang Ndop Total
n (%) n (%) n (%) n n (%) n (%) n (%) n
Children and adolescents enrolled 552 (27.7) 400 (20.1) 1038 (52.1) 1990 1205 (44.1) 623 (22.8) 901 (33.0) 2729
Children and adolescents tested for
HIV in the hospital
257 (27.6) 212 (22.7) 462 (49.6) 931 951 (38.5) 619 (25.1) 895 (36.3) 2465
Children and adolescents tested for
HIV in the community (only tPITC)
43 (21.7) 140 (70.7) 15 (7.5) 198 N/A N/A N/A N/A
Children tested for HIV (both
community and hospital)
300 (26.5) 352 (31.1) 477 (42.2) 1129 951 (38.5) 619 (25.1) 895 (36.3) 2465
Children and adolescents tested
HIV+ in the community
0 (0.0) 1 (100) 0 (0.0) 1 N/A N/A N/A N/A
Children and adolescents tested
HIV+ in the hospital
5 (12.8) 13 (33.3) 21 (53.8) 39 14 (35.0) 21 (52.5) 5 (12.5) 40
Children and adolescents tested
HIV+ (both hospital and community)
5 (12.5) 14 (35.0) 21 (52.5) 40 14 (35.0) 21 (52.5) 5 (12.5) 40
Children and adolescents initiated on ART 1 (2.9) 13 (38.2) 20 (58.8) 34 3 (14.2) 16 (76.1) 2 (9.5) 21
N/A Not applicable
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testing uptake (feasibility) rate was 60.5% compared to
91.2% (p < 0.0001), respectively, in the tPITC and bPITC
groups. In comparison, among children older than 12 years
of age, this rate was 43.8% vs 86.7% (p < 0.0001).
The lack of transport fare (38.4%), children not living
with biological parents (25.6%) and lack of time (10.5%)
were the three primary reasons affecting the feasibility of
tPITC strategy. These reasons were provided by a sub-
group of 86 parents who initially accepted to have their
children tested, but subsequently did not return to the
hospital with their children for HIV testing (Fig. 2).
HIV positivity/case detection
A total of 3594 children and adolescents were tested for
HIV during the recruitment period; 1129 and 2465 in
the tPITC and bPITC group, respectively (Table 1). The
HIV positivity rate (case detection) was 3.5% (95% CI:
2.4–4.5) in tPITC group compared to 1.6% (95CI: 1.1–
2.1) in the bPITC group (p = 0.0008) (Table 2). Among
children ≤12 years, the HIV positivity rate was 3.3% vs
1.4% (p = 0.0006), respectively, in the tPITC and bPITC
groups. In comparison, among children older than 12,
this rate was 4.6% vs. 2.5% (p = 0.1621).
In the tPITC group, 17.of children were tested in the
community and the hospital, respectively. The HIV posi-
tivity rate was 0.5% (1/198) in children tested in the com-
munity compared 4.2% (39/931) (p = 0.0107) among those
tested in the hospital.
Early detection of HIV cases
The proportion of HIV infected children diagnosed at
WHO stage 1 and WHO stage 3 were 84.8% (28/33) and
15.2% (5/33) in the tPITC group, respectively, compared to
21.7% (5/23) and 39.1% (9/23) in the bPITC (p = 0.0001),
respectively.
Linkage to HIV care and treatment
In the tPITC group, 85.0% (34/40) of children tested
HIV+ were linked to HIV treatment compared to 52.5%
(21/40) of the cases in the bPITC (p = 0.0018) (Table 2).
Table 2 Acceptability and effectiveness of targeted versus blanket PITC in three hospitals in Cameroon, ASPA study, July 2015–
November 2016
Outcome tPITC bPITC P*
Limbe Abong-
Mbang
Ndop Total Limbe Abong-
Mbang
Ndop Total
% (n) % (n) % (n) % (n) % (n) % (n) % (n) % (n)
Acceptability
rate
100.0 (327/
327)
99.7 (344/
345)
99.6 (566/
568)
99.8 (1616/
1619)
99.2 (1013/
1021)
99.3 (575/
579)
98.0 (842/
859)
98.8 (2430/
2459)
0.0005
Feasibility rate 54.3 (300/552) 88.0 (352/
400)
46.0 (477/1038) 56.7 (1129/
1990)
78.9 (951/
1205)
99.4 (619/
623)
99.3 (895/
901)
90.3 (2465/
2729)
< 0.0001
HIV positivity
rate
1.7 (5/300) 4.0 (14/352) 4.4 (21/477) 3.5 (40/1129) 1.5 (14/951) 3.4 (21/619) 0.6 (5/895) 1.6 (40/2465) 0.0008
Linkage rate 20.0 (1/5) 92.9 (12/14) 95.2 (20/21) 85.0 (33/40) 21.4 (3/14) 76.2 (16/21) 40.0 (2/5) 52.5 (21/40) 0.0018
*p value comparing the outcome (total) of tPITC vs. bPITC in the 3 study sites
Fig. 2 Reasons of PLHIV for not returning with children for HIV testing, ASPA study, July 2015–November 2016, Cameroon
Yumo et al. BMC Pediatrics  (2018) 18:309 Page 5 of 9
Among children ≤12 years, the linkage rate was 90.3% vs
58.6% (p = 0.005) in the tPITC and bPITC groups, re-
spectively. Among children older than 12 years, this rate
was 66.7% vs. 36.4% (p = 0.3698) in the tPITC and
bPITC groups, respectively.
Discussion
Applying the ambitious 90–90-90 target of the UNAIDS
[13] to pediatrics would require global identification of
3.7 million infants, children and adolescents with HIV
infection, treatment of 3.3 million, and achieving viral sup-
pression among 3 million within the next four years [14].
Pediatric HIV case finding represents a major challenge in
meeting these targets. The findings of this study add to
the growing evidence that targeted strategies may increase
HIV testing uptake, yield and linkage to treatment.
In the tPITC group, we found an HIV positivity rate
(case detection rate/yield) of 3.5%, which was closer to the
4.0% but lower than the 7.4% reported by Saeed et al. in
Malawi [15] and Wagner et al.in Kenya [16], respectively.
The HIV prevalence (4.3%) in the general population in
Cameroon (4.3%) [17] is lower compared to Malawi
(9.2%) and Kenya (5.4%) [8] and this may explain the
lower HIV positivity rate observed among the pediatric
and adolescent population in our study compared to
Malawi and Kenya as reported in the aforementioned
studies. In the bPITC group, we found a prevalence of
1.6%, which was similar to the 1.8% reported by Zoufaly et
al. in rural Cameroon [18] and closer to the 2.7% reported
by Cohn et al. in a meta-analysis [19].
The HIV positivity rates reported by this study imply
that the yield of newly identified HIV cases among chil-
dren was two times higher with tPITC. To identify a
new HIV case, 31 and 62 parents have to be counselled,
and 29 and 63 children have to be tested, in the tPITC
and bPITC groups, respectively. Therefore, less effort is
needed with tPITC to identify a new pediatric or adoles-
cent HIV case, and tPITC is more effective than bPITC
in the context of our study.
The parents’ acceptance (acceptability) of HIV testing
for their children was very high using both strategies
(99.7% in tPITC vs 98.8% in bPITC). The slightly higher
acceptance in the tPITC group may be due to enhanced
HIV awareness resulting from the contact of these par-
ents with HIV services. Ahmed et al. reported a similar
high acceptability (93.5%) in their study in Malawi [15].
The uptake of HIV testing (feasibility) among children
was significantly lower in the tPITC group (56.7% vs
90.3%, p < 0.0001). This may be attributable to the fact
that the tPITC parents living with HIV were initially
seen in the hospital in the first place for their own care,
and their children were less likely to be present. Simi-
larly, low uptake of HIV testing among children in
tPITC was reported in Kenya where only 14% of parents
who had initially consented to test children had followed
through with the testing [16]. In our study, according to
the parents’ declarations, the main reasons for their in-
ability to return to the hospital with their children for
HIV testing included the lack of transport fare (38.3%),
children not living with them (25.6%), and the lack of
time (10.5%). These reasons should be taken with cau-
tion because the HIV testing uptake could have also
been limited by parental’ levels barriers, notably fear of
self-disclosure, stigma and discrimination as reported by
previous studies [4, 16, 20–22]. There is a need for
qualitative research to provide in-depth information on
parental barriers to the uptake of HIV testing for chil-
dren in the context of tPITC approach implementation.
Although the HIV testing uptake was highest (90.3%)
in the bPITC, nearly 10% of the children enrolled were
not ultimately tested. This finding was attributable to a
fraction of parents who initially consented to test their
children, but they subsequently changed their decisions
and did not go to the laboratory for testing. A number
may have gone to the laboratory, but due to the long
waiting time, they may have decided to leave without
testing the child. Conducting the HIV testing on the
spot or having a dedicated testing room for these chil-
dren near the counseling office may have reduced the
missed opportunity for testing.
In this study, pediatric HIV cases were diagnosed earl-
ier in the tPITC group (84.8% at WHO stage 1) because
this strategy tested asymptomatic children in contrast to
the bPITC, in which children tested were evaluated for
an illness (34.8% at WHO stage 2 and 39.1% at WHO
stage 3). This finding was consistent with a previous tar-
geted pediatric HIV testing in Malawi, where a large
proportion (46.7%) of HIV infected children were diag-
nosed at WHO stage 1 [15]. Therefore, a pediatric HIV
program could prioritize the tPITC strategy for early
case identification as a means to reduce the high mortal-
ity rate associated with non-treatment of children living
with HIV [23–25]. Linkage to care was significantly
higher in the tPITC group (85.0% vs 52.5%, p = 0.0018).
This finding may be explained by the fact that the large
majority of parents were already in HIV care (96% of
children were identified through parents on ART) and it
was easier to link the children to HIV services because
the parents, having seen the benefit of ART, quickly
seized the treatment opportunity offered for their chil-
dren who tested positive for HIV. This finding highlights
the potential effect that prior enrolment of parents on
ART could have on linkage of their children to care. This
further demonstrates the effectiveness of the HIV care
family-centered approach in enhancing pediatric HIV link-
age and retention in care [26–29]. Nevertheless, in Limbe
Regional Hospital, the linkage rate was statistically similar
in the tPITC and bPITC groups (20.0% vs 21.4%, p = 1),
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but this rate was higher (but not statistically significant) in
the tPITC group in Abong-Mbang (92.9% vs 76.2%, p =
0.2054) and significantly higher in Ndop (95.2% vs 40.0%,
p = 0.0144) district hospital. In Abong-Mbang and Ndop
district hospitals, we assigned staff members (linkage
agents) to ensure that all children who tested positive for
HIV were linked to care. Moreover, in these two new sites
(through the humanitarian component of the ASPA pro-
ject), nutritional kits were provided to HIV-positive chil-
dren in care. Neither the linkage agent nor the nutritional
support was provided at the Limbe Regional Hospital,
which had the lowest linkage rate among the three sites.
This finding suggests that both the linkage agent and nutri-
tional support may have contributed meaningfully in im-
proving linkage in the tPITC and bPITC groups. The
positive effect of nutritional support in the linkage and re-
tention of children in care has been previously demon-
strated [30]. There is a need to further investigate this
effect when combined with a linkage agent.
The limitations of this study were that the Limbe Re-
gional Hospital began implementation in July 2015,
while the Abong-Mbang and Ndop District Hospitals
began later, in June 2016. We tweaked the implementa-
tion strategies in these 2 additional sites from lessons
learned from the first site. In particular, we reinforced
the follow-up of children diagnosed HIV+ to enhance
linkage (introduction of a linkage agent). We also intro-
duced the provision of nutritional kits to HIV+ children
in care. These additional interventions may have con-
tributed to increase the linkage rate in these 2 sites com-
pared to Limbe. Thus, the results of Limbe Regional
Hospital and that of Abong-Mbang and Ndop District
Hospital are not comparable in all aspects. Nevertheless,
because the primary objective of the study was not to
compare the outcome per site, but rather, to compare
the outcome of both tPITC and bPITC, the time differ-
ence in implementation per site did not affect the results
of the study. In contrast, this stepwise implementation
approach was found very useful because lessons learned
from the first site (Limbe) informed the adjustments
needed to have a more robust strategy for better linkage
to care of HIV-positive children. Another potential limi-
tation was that critically ill children were not included in
our study. However, the number of these children com-
ing to the hospital is usually marginal and their exclu-
sion would not have affected our findings.
Conclusions
The tPITC and bPITC strategies were highly acceptable
to parents to support HIV testing for their children. The
tPITC had a higher yield and provided an opportunity
for early detection of pediatric and adolescent HIV cases
as well as linkage to care before these children become
sick and present to the health facility with HIV clinical
manifestations.
However, the feasibility of tPITC strategy was lower
compared to bPITC, which was due to the low HIV test-
ing uptake among children and adolescents in the former
strategy. The bPITC had a higher HIV testing uptake, but
a lower linkage rate. Thus, the clinical cascade for the
tPITC is challenged by the HIV testing uptake gap while
that of the bPITC is constrained by the ART linkage gap.
Overall, the ASPA study demonstrated the superiority
of tPITC over bPITC in terms of case detection, case de-
tection earliness, and linkage to care and treatment.
However, when the required resources are available,
both strategies may be promoted to fast track the
achievement of the ambitious 90–90-90 targets of the
UNAIDS among children and adolescents by 2020.
Meeting this objective would require the implementation
of strategies that are suitable to optimize the outcome of
both tPITC and bPITC approaches by improving the
HIV testing uptake and linkage to care and treatment,
respectively.
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